DK1354599T3 - Farmaceutisk sammensætning eller fødevare til behandling af patologiske tilstande forbundet med afstødning af transplantater - Google Patents

Farmaceutisk sammensætning eller fødevare til behandling af patologiske tilstande forbundet med afstødning af transplantater

Info

Publication number
DK1354599T3
DK1354599T3 DK03017072.4T DK03017072T DK1354599T3 DK 1354599 T3 DK1354599 T3 DK 1354599T3 DK 03017072 T DK03017072 T DK 03017072T DK 1354599 T3 DK1354599 T3 DK 1354599T3
Authority
DK
Denmark
Prior art keywords
food
treatment
pharmaceutical composition
conditions associated
pathological conditions
Prior art date
Application number
DK03017072.4T
Other languages
English (en)
Inventor
Jean Duchateau
Genevieve Servais
Original Assignee
Biotech Tools Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Tools Sa filed Critical Biotech Tools Sa
Application granted granted Critical
Publication of DK1354599T3 publication Critical patent/DK1354599T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK03017072.4T 1997-03-05 1998-03-05 Farmaceutisk sammensætning eller fødevare til behandling af patologiske tilstande forbundet med afstødning af transplantater DK1354599T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9700199A BE1011033A6 (fr) 1997-03-05 1997-03-05 Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
EP98909232A EP0975362B1 (fr) 1997-03-05 1998-03-05 Composition pharmaceutique ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune

Publications (1)

Publication Number Publication Date
DK1354599T3 true DK1354599T3 (da) 2011-02-07

Family

ID=3890389

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03017072.4T DK1354599T3 (da) 1997-03-05 1998-03-05 Farmaceutisk sammensætning eller fødevare til behandling af patologiske tilstande forbundet med afstødning af transplantater
DK98909232T DK0975362T3 (da) 1997-03-05 1998-03-05 Farmaceutisk sammensætning eller fødevaresammensætning til behandling af patologiske tilstande knyttet til transplantatafstødning, allergiske eller autoimmune reaktioner

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK98909232T DK0975362T3 (da) 1997-03-05 1998-03-05 Farmaceutisk sammensætning eller fødevaresammensætning til behandling af patologiske tilstande knyttet til transplantatafstødning, allergiske eller autoimmune reaktioner

Country Status (10)

Country Link
US (1) US6312711B1 (da)
EP (2) EP1354599B1 (da)
JP (1) JP4554728B2 (da)
AT (2) ATE246003T1 (da)
BE (1) BE1011033A6 (da)
CA (1) CA2283143C (da)
DE (2) DE69816796T2 (da)
DK (2) DK1354599T3 (da)
ES (2) ES2201453T3 (da)
WO (1) WO1998039029A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709672B2 (en) * 1997-03-05 2004-03-23 Biotech Tools S.A. Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US20020012667A1 (en) * 2000-05-16 2002-01-31 Mcmichael John Method for preventing allograft rejection
JP2004505894A (ja) * 2000-06-02 2004-02-26 ユニバーシティー　オブ　コネティカット　ヘルス　センター 免疫療法のためのα（２）マクログロブリンと抗原分子との複合体
WO2002070005A1 (en) * 2001-02-28 2002-09-12 Immvarx, Incorporated Compositions of multimeric profilin for diagnosis and treatment of allergies
EP1536829A4 (en) * 2001-08-20 2006-05-31 Univ Connecticut Health Ct METHOD FOR PRODUCING COMPOSITIONS WITH HEAT SHOCK PROTEINS OR ALPHA-2-MACROGLOBULIN FOR THE TREATMENT OF CANCER AND INFECTION DISEASES
RU2324493C2 (ru) * 2003-02-20 2008-05-20 Юниверсити Оф Коннектикут Хелт Сентер Способ применения композиций, содержащих белки теплового шока или альфа-2-макроглобулин, для лечения рака и инфекционных болезней
JP2008500006A (ja) * 2003-05-21 2008-01-10 バイオテック トゥールス ソシエテ アノニム ペプチド複合体
EP1479689A1 (en) * 2003-05-21 2004-11-24 Biotech Tools S.A. Peptide complex
US8436136B2 (en) * 2003-05-21 2013-05-07 Biotech Tools S.A. Peptide complex
EP1641488B1 (en) 2003-06-23 2011-03-30 Biotech Tools S.A. Epitope composition for enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
US20070292446A9 (en) * 2003-06-23 2007-12-20 Biotech Tools S.A. Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
WO2010086418A1 (en) 2009-01-29 2010-08-05 Alfa Biogene International B.V. Functional food product comprising heat shock protein or a hydrolysate thereof
WO2013011095A1 (en) 2011-07-21 2013-01-24 Biotech Tools S.A. Dosage of dnak
EP3522921B1 (en) 2016-10-05 2020-12-23 ASIT BioTech s.a. Prevention of allergy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0700445T3 (da) * 1993-06-04 2002-05-13 Whitehead Biomedical Inst Stressproteiner og anvendelser deraf
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
BE1008817A6 (fr) 1994-10-28 1996-08-06 Univ Bruxelles Procede d'obtention d'adn bicatenaire membranaire humain, produit obtenu par ce procede et trousse de diagnostic le contenant.
JP3656277B2 (ja) * 1995-05-17 2005-06-08 味の素株式会社 組換えｄｎａ法によるトランスグルタミナーゼの効率的製造法
BE1009359A7 (fr) 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
WO1997006685A1 (en) * 1995-08-18 1997-02-27 Sloan-Kettering Institute For Cancer Research Method for treatment of cancer and infectious diseases and compositions useful in same
EP0941315B1 (en) * 1996-11-26 2006-03-01 Stressgen Biotechnologies Corporation Fusion proteins containing stress proteins for inducing immune responses
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes

Also Published As

Publication number Publication date
ES2201453T3 (es) 2004-03-16
JP2001514623A (ja) 2001-09-11
DK0975362T3 (da) 2003-11-10
CA2283143A1 (fr) 1998-09-11
EP1354599B1 (fr) 2010-10-20
WO1998039029A3 (fr) 1999-01-14
EP0975362B1 (fr) 2003-07-30
JP4554728B2 (ja) 2010-09-29
CA2283143C (fr) 2014-05-27
EP1354599A2 (fr) 2003-10-22
ATE485054T1 (de) 2010-11-15
EP0975362A2 (fr) 2000-02-02
DE69816796D1 (de) 2003-09-04
BE1011033A6 (fr) 1999-04-06
WO1998039029A2 (fr) 1998-09-11
EP1354599A3 (fr) 2003-12-10
US6312711B1 (en) 2001-11-06
ES2354941T3 (es) 2011-03-21
DE69816796T2 (de) 2004-05-27
DE69841966D1 (de) 2010-12-02
ATE246003T1 (de) 2003-08-15

Similar Documents

Publication Publication Date Title
DK1354599T3 (da) Farmaceutisk sammensætning eller fødevare til behandling af patologiske tilstande forbundet med afstødning af transplantater
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
EP1231218A3 (en) An appetite-suppressing peptide, its compositions and use
NO884840D0 (no) Fremgangsmaate for behandling av underjordiske formasjoner med gelfluider som gir forsinket kryssbinding.
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
NO20002957L (no) Behandling med anti-ErbB2-antistoffer
DE69938302D1 (de) Neisseria meningitidis antigene und zusammenstellungen
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
DE3687769D1 (de) Vakzine und diagnostika, die vom bovine-diarrhea-virus stammen.
DE3853341D1 (de) Form zur verzögerten Diltiazemfreisetzung sowie das daraus hergestellte Arzneimittel.
IT1231047B (it) Riscaldatore per autoveicoli o simili.
PT946873E (pt) Metodos para diagnostico da aspergilose broncopulmonar alergica
PT101542A (pt) Armacao para uma de cozinheiro.
NO973533D0 (no) Kombinasjonsterapi mot HIV infeksjon ved anvendelse av proteaseinhibitoren indinavir og revers-transskriptaseinhibitoren 3TC, eventuelt sammen med AZT, DDI eller DDC
DE69110088D1 (de) Hitzebeständiger Klebstoff und diesen anwendendes Klebeverfahren.
DK0951289T3 (da) Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom
NO893037L (no) Anordning for sjoebunn-understoettelse av plattform-ben, samt plattform med slike anordninger.
DE69103701D1 (de) Enzymatisch modifizierter Protein und Verfahren zur Herstellung desselben.
TR199802118A3 (tr) Egzoz gazlarinin aritilmasi için yöntem ve düzenleme.
MX9102498A (es) Mezclas de multipolimeros de acrilico modificados con caucho, u policarbonatos; y metodo para la fabricacion de las mismas.
EP0401379A4 (en) Stabilized composition of interleukin-1-g(b)
DE69103510D1 (de) Regale und Beschlag dafür.
ES1008267Y (es) Rampa perfeccionada, para grifos de gas.
ES1023689Y (es) Calentador por induccion para el montaje de rodamientos, poleas objetos huecos y similares perfeccionado.
ES1036949Y (es) Percha de arco para fladas, dotada de pinzas.